Copyright: ©Author(s) 2026.
World J Methodol. Jun 20, 2026; 16(2): 113265
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.113265
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.113265
Table 3 Key clinical outcomes summary
| Agent | Studies (n) | Thrombotic events (%) | Major bleeding (%) | Mortality (%) |
| Fondaparinux | 4 | 0-15.4 | 5.1-11.1 | 5.9-9.3 |
| Argatroban | 6 | 5.9-21.7 | 5.9-14.5 | 0-21.7 |
| Bivalirudin | 3 | 7.5-16.9 | 7.8-15.8 | 12.4-20.0 |
| Overall range | 16 | 0-30 | 5-15 | 0-22 |
- Citation: Rehman A, Abid M, Jamil H, Siddique S, Parkash S, Nasrullah F, Sapna F, Lohana B, Lohana K, Jawed I, Tufail M, Sharaf MS. Comparative effectiveness of parenteral anticoagulants (fondaparinux, argatroban, bivalirudin) in heparin-induced thrombocytopenia: A systematic review. World J Methodol 2026; 16(2): 113265
- URL: https://www.wjgnet.com/2222-0682/full/v16/i2/113265.htm
- DOI: https://dx.doi.org/10.5662/wjm.v16.i2.113265